Annual industry ranking and forecast
The full Scrip 100 data set for 2022 is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2020).
If you are a subscriber, you may download the data in Excel format.
Pfizer has dropped to number seven in our top pharma rankings after a long reign. AbbVie has risen to number three, growing through merger expansion.
The Scrip 100 universe gathers FY 2020 financial performance data and compares the activities of the top 100 biopharma businesses, ranked by pharma sales.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.